Law360, New York (November 08, 2010, 6:29 PM ET) -- Johnson & Johnson Inc. subsidiary Centocor Ortho Biotech Inc. has failed to persuade a federal judge to throw out a suit a patient filed over a warning label developed for Remicade.
Judge James G. Carr of the U.S. District Court for the Northern District of Ohio ruled that Centocor had not, as a matter of law, warned patient Anthony DeGidio that he might contract a noninfectious lung disease if he used Remicade.
The warning did mention that Remicade might cause an infectious lung disease, but had...
Centocor Loses Bid To Dismiss Remicade Suit
To view the full article, take a free trial now.
